[
    {
        "header": "Abstract",
        "images": []
    },
    {
        "header": "1Introduction",
        "images": []
    },
    {
        "header": "2Results",
        "images": [
            {
                "img": "https://arxiv.org/html/2508.18579/x1.png",
                "caption": "Figure 1:Schematic representation of DrugReasoner development and assessment.The upper panel illustrates dataset preparation and processing. The lower panel shows model training with group relative policy optimization (GRPO) using customized reward functions, followed by comparative evaluation against other models on validation, test, and external datasets.",
                "position": 139
            },
            {
                "img": "https://arxiv.org/html/2508.18579/x2.png",
                "caption": "Figure 2:DrugReasoner assessment.(A) Reward trajectory during group relative policy optimization (GRPO) training with exponential moving average (EMA).\n(B) Evaluation metrics of model on the validation set.\n(C) Comparative performance of DrugReasoner and baseline models on the validation set.\n(D) Comparative performance on the test set.\n(E) Comparative performance of DrugReasoner with baseline models and ChemAP on an independent external dataset.",
                "position": 148
            }
        ]
    },
    {
        "header": "3Discussion",
        "images": []
    },
    {
        "header": "4Methods",
        "images": []
    },
    {
        "header": "5Data availability",
        "images": []
    },
    {
        "header": "6Code availability",
        "images": []
    },
    {
        "header": "7Acknowledgment",
        "images": []
    },
    {
        "header": "8Funding",
        "images": []
    },
    {
        "header": "9Competing interest",
        "images": []
    },
    {
        "header": "10Authors contribution",
        "images": []
    },
    {
        "header": "References",
        "images": []
    }
]